NDC 81052-138

Cytalux

Pafolacianine Injection

Cytalux is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by On Target Laboratories, Inc.. The primary component is Pafolacianine Sodium.

• Product ID: 81052-138_d2af4d60-d420-c158-e053-2a95a90ad01f
• NDC: 81052-138
• Product Type: Human Prescription Drug
• Proprietary Name: Cytalux
• Generic Name: Pafolacianine Injection
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-11-29
• Marketing Category: NDA /
• Application Number: NDA214907
• Labeler Name: On Target Laboratories, Inc.
• Substance Name: PAFOLACIANINE SODIUM
• Active Ingredient Strength: 3 mg/1.6mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 81052-138-10

10 CARTON in 1 CARTON (81052-138-10) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 1.6 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2021-11-29
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details